<- Go Home

Parexel International Corporation

Parexel International Corporation operates as a biopharmaceutical outsourcing company that provides clinical research and logistics, medical communications, consulting, and technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide.

Market Cap

EUR 4.5B

Volume

885.8K

Cash and Equivalents

EUR 302.7M

EBITDA

EUR 340.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 740.1M

Profit Margin

34.95%

52 Week High

EUR 88.10

52 Week Low

EUR 51.16

Dividend

N/A

Price / Book Value

7.09

Price / Earnings

42.76

Price / Tangible Book Value

-108.19

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

EUR 233.7M

Return on Equity

16.93%

Return on Assets

6.72

Cash and Short Term Investments

EUR 302.7M

Debt

EUR 671.5M

Equity

EUR 634.5M

Revenue

EUR 2.1B

Unlevered FCF

EUR 255.3M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches